ADC Therapeutics Statistics

Total Valuation

ADCT has a market cap or net worth of $334.87 million. The enterprise value is $223.48 million.

Market Cap	334.87M
Enterprise Value	223.48M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, before market open.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

ADCT has 96.23 million shares outstanding. The number of shares has increased by 2.16% in one year.

Shares Outstanding	96.23M
Shares Change (YoY)	+2.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	21.09%
Owned by Institutions (%)	40.52%
Float	67.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.88
Forward PS	4.09
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.61

Current Ratio	4.61
Quick Ratio	4.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-55.50%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$251,352
Profits Per Employee	-$832,355
Employee Count	273
Asset Turnover	0.17
Inventory Turnover	0.26

Taxes

In the past 12 months, ADCT has paid $39.53 million in taxes.

Income Tax	39.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.86% in the last 52 weeks. The beta is 1.62, so ADCT's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	+61.86%
50-Day Moving Average	3.76
200-Day Moving Average	2.75
Relative Strength Index (RSI)	54.39
Average Volume (20 Days)	1,202,829

Short Selling Information

The latest short interest is 822,449, so 0.85% of the outstanding shares have been sold short.

Short Interest	822,449
Short Previous Month	1.00M
Short % of Shares Out	0.85%
Short % of Float	1.22%
Short Ratio (days to cover)	1.19

Income Statement

In the last 12 months, ADCT had revenue of $68.62 million and -$227.23 million in losses. Loss per share was -$2.77.

Revenue	68.62M
Gross Profit	64.17M
Operating Income	-148.03M
Pretax Income	-187.70M
Net Income	-227.23M
EBITDA	-135.32M
EBIT	-138.73M
Loss Per Share	-$2.77

Full Income Statement

Balance Sheet

The company has $234.29 million in cash and $122.90 million in debt, giving a net cash position of $111.39 million or $1.16 per share.

Cash & Cash Equivalents	234.29M
Total Debt	122.90M
Net Cash	111.39M
Net Cash Per Share	$1.16
Equity (Book Value)	-194.45M
Book Value Per Share	-2.02
Working Capital	227.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$154.12 million and capital expenditures -$2.73 million, giving a free cash flow of -$156.85 million.

Operating Cash Flow	-154.12M
Capital Expenditures	-2.73M
Free Cash Flow	-156.85M
FCF Per Share	-$1.90

Full Cash Flow Statement

Margins

Gross margin is 93.52%, with operating and profit margins of -215.72% and -331.15%.

Gross Margin	93.52%
Operating Margin	-215.72%
Pretax Margin	-273.54%
Profit Margin	-331.15%
EBITDA Margin	-197.20%
EBIT Margin	-202.18%
FCF Margin	-228.58%

Dividends & Yields

ADCT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.16%
Shareholder Yield	-2.16%
Earnings Yield	-67.86%
FCF Yield	-46.84%

Analyst Forecast

The average price target for ADCT is $7.00, which is 101.15% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	101.15%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	34.48%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ADCT has an Altman Z-Score of -6.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.26
Piotroski F-Score	1